1. Abdool Karim, Q., Abdool Karim, S. S., Frohlich, J. A., Grobler, A. C., Baxter, C., Mansoor, L. E., … Taylor, D. (2010). Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science, 329, 1168–1174.
2. Anton, P., Cranston, R., Carballo-Dieguez, A., Kashuba, A., Khanukhova, E., Elliott, J., … McGowan, I. (2011). RMP-02/MTN-006: A phase 1, placebo-controlled trial of rectally applied 1% vaginal Tenofovir gel with comparison to oral Tenofovir Disoproxil Fumarate. Paper presented at the conference on Retroviruses and Opportunistic Infections, Boston, MA.
3. Bass, E. (2002). IAVI report—Learning from microbicides: A young field’s experience working with high-risk women. AIDScience, 2(17). Retrieved from http://aidscience.org/Articles/iavi007.asp .
4. Dezzutti, C. S., Rohan, L. C., Wang, L., Uranker, K., Shetler, C., Cost, M., … Friend, D. (2012). Reformulated tenofovir gel for use as a dual compartment microbicide. Journal of Antimicrobial Chemotherapy, 67, 2139–2142.
5. Greene, E., Batona, G., Hallad, J., Johnson, S., Neema, S., & Tolley, E. E. (2010). Acceptability and adherence of a candidate microbicide gel among high-risk women in Africa and India. Culture, Health, & Sexuality, 12, 739–754.